Bortezomib Overcomes Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
Open Access
- 1 April 2009
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 284 (17), 11121-11133
- https://doi.org/10.1074/jbc.m806268200
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Proteasome inhibitor Bortezomib induces cell-cycle arrest and apoptosis in cell lines derived from Ewing’s sarcoma family of tumors and synergizes with TRAILCancer Biology & Therapy, 2008
- Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinomaCancer, 2003
- Apo2L/TRAIL and its death and decoy receptorsCell Death & Differentiation, 2003
- NF-κB as a therapeutic target in cancerTrends in Molecular Medicine, 2002
- An Inducible Pathway for Degradation of FLIP Protein Sensitizes Tumor Cells to TRAIL-induced ApoptosisJournal of Biological Chemistry, 2002
- TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLOGenes & Development, 2002
- Identification of Inhibitors of TRAIL-induced Death (ITIDs) in the TRAIL-sensitive Colon Carcinoma Cell Line SW480 Using a Genetic ApproachJournal of Biological Chemistry, 2001
- CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-κB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cellsOncogene, 2001
- Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.2001
- The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.2001